We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Genworth Financial
GNW
$3.76B
| $178K | ﹤0.01% |
38,541
-22,225
| -37% | -$131K |
|
802
Iovance Biotherapeutics
IOVA
$1.82B
| $178K | ﹤0.01% |
30,900
-1,100
| -3% | -$8.57K |
|
|
CBL
803
DELISTED
CBL& Associates Properties, Inc.
CBL
| $177K | ﹤0.01% |
12,853
-10,378
| -45% | -$161K |
|
804
Dana Inc
DAN
$2.9B
| $175K | ﹤0.01% |
11,002
-27,299
| -71% | -$493K |
|
805
MDU Resources
MDU
$4.17B
| $173K | ﹤0.01% |
+26,501
| New | +$180K |
|
806
ICICI Bank
IBN
$108B
| $172K | ﹤0.01% |
+22,550
| New | +$193K |
|
|
RFP
807
DELISTED
Resolute Forest Products Inc.
RFP
| $169K | ﹤0.01% |
+20,290
| New | +$197K |
|
808
Diamondrock Hospitality Co
DRH
$2.71B
| $163K | ﹤0.01% |
+14,770
| New | +$182K |
|
|
TERP
809
DELISTED
TerraForm Power, Inc
TERP
| $158K | ﹤0.01% |
11,099
-8,523
| -43% | -$228K |
|
|
SWN
810
DELISTED
Southwestern Energy Company
SWN
| $155K | ﹤0.01% |
12,200
+2,060
| +20% | +$35.8K |
|
|
ORBK
811
DELISTED
Orbotech Ltd
ORBK
| $155K | ﹤0.01% |
+10,000
| New | +$175K |
|
|
FRAN
812
DELISTED
Francesca's Holdings Corporation
FRAN
| $154K | ﹤0.01% |
1,052
-1,781
| -63% | -$258K |
|
|
CIE
813
DELISTED
Cobalt International Energy, Inc
CIE
| $149K | ﹤0.01% |
+1,401
| New | +$171K |
|
|
PRMW
814
DELISTED
Primo Water Corporation
PRMW
| $148K | ﹤0.01% |
+13,700
| New | +$148K |
|
815
Marvell Technology
MRVL
$168B
| $141K | ﹤0.01% |
15,555
-493,465
| -97% | -$5.62M |
|
816
Invesco Mortgage Capital
IVR
$759M
| $132K | ﹤0.01% |
+1,082
| New | +$151K |
|
817
Wabash National
WNC
$512M
| $131K | ﹤0.01% |
+12,400
| New | +$152K |
|
|
HMSY
818
DELISTED
HMS Holdings Corp.
HMSY
| $131K | ﹤0.01% |
+14,902
| New | +$166K |
|
|
PVA
819
DELISTED
PENN VIRGINIA CORP
PVA
| $130K | ﹤0.01% |
+243,987
| New | +$373K |
|
|
MFA
820
MFA Financial
MFA
$926M
| $123K | ﹤0.01% |
+4,517
| New | +$133K |
|
821
Annaly Capital Management
NLY
$17.1B
| $123K | ﹤0.01% |
3,104
+363
| +13% | +$14.5K |
|
|
CMO
822
DELISTED
Capstead Mortgage Corp.
CMO
| $123K | ﹤0.01% |
+12,405
| New | +$135K |
|
|
ZNGA
823
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $122K | ﹤0.01% |
53,610
+29,392
| +121% | +$75.2K |
|
|
VER
824
DELISTED
VEREIT, Inc.
VER
| $122K | ﹤0.01% |
+3,171
| New | +$132K |
|
|
ONIT
825
Onity Group
ONIT
$309M
| $120K | ﹤0.01% |
+1,194
| New | +$151K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.